Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 110

    1.

    The transplant iron score as a predictor of stem cell transplant survival.

    Storey JA, Connor RF, Lewis ZT, Hurd D, Pomper G, Keung YK, Grover M, Lovato J, Torti SV, Torti FM, Molnár I.

    J Hematol Oncol. 2009 Oct 24;2:44.

    PMID:
    19852846
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    3.

    Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study.

    Alessandrino EP, Della Porta MG, Bacigalupo A, Malcovati L, Angelucci E, Van Lint MT, Falda M, Onida F, Bernardi M, Guidi S, Lucarelli B, Rambaldi A, Cerretti R, Marenco P, Pioltelli P, Pascutto C, Oneto R, Pirolini L, Fanin R, Bosi A.

    Haematologica. 2010 Mar;95(3):476-84. Epub 2009 Nov 10.

    PMID:
    19903678
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.

    Lim ZY, Fiaccadori V, Gandhi S, Hayden J, Kenyon M, Ireland R, Marsh J, Ho AY, Mufti GJ, Pagliuca A.

    Leuk Res. 2010 Jun;34(6):723-7. Epub 2009 Nov 26.

    PMID:
    19944463
    [PubMed - indexed for MEDLINE]
    5.

    Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.

    Sucak GT, Yegin ZA, Ozkurt ZN, Aki SZ, Yağci M.

    Transplant Proc. 2010 Jun;42(5):1841-8.

    PMID:
    20620535
    [PubMed - indexed for MEDLINE]
    6.

    Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.

    Raptis A, Duh MS, Wang ST, Dial E, Fanourgiakis I, Fortner B, Paley C, Mody-Patel N, Corral M, Scott J.

    Transfusion. 2010 Jan;50(1):190-9. Epub 2009 Aug 28.

    PMID:
    19719471
    [PubMed - indexed for MEDLINE]
    7.

    Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes.

    Malcovati L.

    Leuk Res. 2007 Dec;31 Suppl 3:S2-6. Review.

    PMID:
    18037415
    [PubMed - indexed for MEDLINE]
    8.

    Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.

    Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, Soiffer RJ, Antin JH.

    Blood. 2007 May 15;109(10):4586-8. Epub 2007 Jan 18.

    PMID:
    17234738
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

    Leitch HA.

    Drugs. 2011 Jan 22;71(2):155-77. doi: 10.2165/11585280-000000000-00000. Review.

    PMID:
    21275444
    [PubMed - indexed for MEDLINE]
    10.

    Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.

    Armand P, Kim HT, Rhodes J, Sainvil MM, Cutler C, Ho VT, Koreth J, Alyea EP, Hearsey D, Neufeld EJ, Fleming MD, Steen H, Anderson D, Kwong RY, Soiffer RJ, Antin JH.

    Biol Blood Marrow Transplant. 2011 Jun;17(6):852-60. Epub 2010 Sep 18.

    PMID:
    20854920
    [PubMed - indexed for MEDLINE]
    11.

    Final Report on Carcinogens Background Document for Styrene.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.

    PMID:
    20737009
    [PubMed - as supplied by publisher]
    12.

    Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis.

    Altes A, Remacha AF, Sarda P, Sancho FJ, Sureda A, Martino R, Briones J, Brunet S, Canals C, Sierra J.

    Bone Marrow Transplant. 2004 Sep;34(6):505-9.

    PMID:
    15286693
    [PubMed - indexed for MEDLINE]
    13.

    Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.

    Ballas SK.

    Semin Hematol. 2001 Jan;38(1 Suppl 1):30-6.

    PMID:
    11206959
    [PubMed - indexed for MEDLINE]
    14.

    Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.

    Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A.

    Biol Blood Marrow Transplant. 2010 Jan;16(1):115-22. Epub 2009 Sep 18.

    PMID:
    19766730
    [PubMed - indexed for MEDLINE]
    15.

    Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

    Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.

    Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8.

    PMID:
    19135940
    [PubMed - indexed for MEDLINE]
    16.

    Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.

    Kowdley KV, Brandhagen DJ, Gish RG, Bass NM, Weinstein J, Schilsky ML, Fontana RJ, McCashland T, Cotler SJ, Bacon BR, Keeffe EB, Gordon F, Polissar N; National Hemochromatosis Transplant Registry.

    Gastroenterology. 2005 Aug;129(2):494-503.

    PMID:
    16083706
    [PubMed - indexed for MEDLINE]
    17.

    Myelodysplastic syndromes and the role of iron overload.

    Harvey RD.

    Am J Health Syst Pharm. 2010 Apr;67(7 Suppl 2):S3-9.

    PMID:
    20332503
    [PubMed - indexed for MEDLINE]
    18.

    [Myelodysplastic syndromes. Diagnosis and therapeutic strategies].

    Aul C, Giagounidis A, Germing U, Ganser A.

    Med Klin (Munich). 2002 Nov 15;97(11):666-76. Review. German.

    PMID:
    12434275
    [PubMed - indexed for MEDLINE]
    19.

    Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.

    Kim YR, Kim JS, Cheong JW, Song JW, Min YH.

    Acta Haematol. 2008;120(3):182-9. Epub 2009 Jan 5.

    PMID:
    19129689
    [PubMed - indexed for MEDLINE]
    20.

    Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation.

    Altès A, Remacha AF, Sureda A, Martino R, Briones J, Canals C, Brunet S, Sierra J, Gimferrer E.

    Bone Marrow Transplant. 2002 Jun;29(12):987-9.

    PMID:
    12098067
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk